Salvage Radiotherapy Versus Hormone Therapy for Prostate-specific Antigen Failure After Radical Prostatectomy: A Randomised, Multicentre, Open-label, Phase 3 Trial (JCOG0401)†

Volume: 77, Issue: 6, Pages: 689 - 698
Published: Jun 1, 2020
Abstract
Background null No standard therapy has been established for localised prostate cancer patients with prostate-specific antigen (PSA) failure after radical prostatectomy (RP). null null null Objective null To determine whether radiotherapy ± hormone therapy is superior to hormone therapy alone in such patients. null null null Design, setting, and participants null This study is a multicentre, randomised, open-label, phase 3 trial. Patients with...
Paper Details
Title
Salvage Radiotherapy Versus Hormone Therapy for Prostate-specific Antigen Failure After Radical Prostatectomy: A Randomised, Multicentre, Open-label, Phase 3 Trial (JCOG0401)†
Published Date
Jun 1, 2020
Volume
77
Issue
6
Pages
689 - 698
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.